Diagnosis: Pyoderma gangrenosum
A 45-year-old female presents with a rapidly expanding, painful ulcer on her lower extremity, characterized by a violaceous undermined border. The lesion has progressed over two weeks, prompting evaluation for potential underlying systemic conditions associated with cutaneous ulceration.
A 45-year-old female presents with a two-week history of a rapidly expanding, painful ulcer on the right lower leg. The lesion has a violaceous undermined border and is tender to palpation. Initial examination reveals surrounding erythema and edema, with no signs of infection.Location: Right lower leg.Size: Approximately 5 cm in diameter.Characteristics: Ulcerated, with a necrotic base.Surrounding skin: Edematous and erythematous.Systemic signs: No fever or systemic symptoms noted.
The ulcer developed without any preceding trauma or known infections. The patient reports a history of inflammatory bowel disease diagnosed 5 years prior, currently in remission. No recent medications or changes in health status were noted. Family history is significant for autoimmune conditions.Onset: Lesion appeared 2 weeks ago.Triggers: No identifiable triggers reported.Prior treatments: Topical antibiotics were applied without improvement.Past medical history: Inflammatory bowel disease.Social history: Non-smoker, no recent travel.
Acute / First-Line ManagementTopical corticosteroids: High-potency topical corticosteroids (e.g., clobetasol propionate) may be applied to the ulcerated area.Systemic corticosteroids: Prednisone 0.5-1 mg/kg/day can be initiated for moderate to severe cases.Wound care: Proper dressing and wound care to maintain a moist environment and prevent secondary infection.Workup and Diagnostic ConfirmationBiopsy: Consider punch biopsy to rule out other conditions such as vasculitis or malignancy.Laboratory tests: Complete blood count, inflammatory markers (CRP, ESR), and serologies for associated systemic diseases.Long-Term ManagementImmunosuppressive therapy: If the response to corticosteroids is inadequate, consider azathioprine or mycophenolate mofetil.Monitoring: Regular follow-up to assess wound healing and manage potential side effects of therapy.Referral: Dermatology and possibly rheumatology for multidisciplinary management.
Necrotizing fasciitis: Rapidly progressing infection with systemic toxicity; often presents with severe pain and systemic signs.Vasculitis: May present with ulcers; differentiated by systemic symptoms and specific serological markers.Malignancy (e.g., squamous cell carcinoma): Persistent ulceration, especially in sun-exposed areas; biopsy required for confirmation.Sweet's syndrome: Associated with fever and neutrophilic dermatosis; often presents with painful papules or plaques.Traumatic ulcer: History of trauma or injury leading to ulceration; may have a clear history of onset.Diabetic ulcer: Common in patients with diabetes; typically occurs on pressure points and associated with neuropathy.Infectious ulcers (e.g., pyogenic granuloma): Can present similarly but often have a history of trauma or irritation.
High-Yield PearlsDiagnosis criteria: Diagnosis often requires exclusion of other causes of ulcers, with a characteristic violaceous border being suggestive.Associated conditions: Often associated with systemic diseases such as inflammatory bowel disease and rheumatoid arthritis.Management: Corticosteroids are the first-line treatment, but immunosuppressive therapy may be necessary for refractory cases.Wound care: Proper wound management is crucial to promote healing and prevent infection.Multidisciplinary approach: Collaboration with rheumatology may provide comprehensive care for underlying systemic conditions.Remember: Pyoderma gangrenosum can present with rapid ulceration and may be associated with systemic diseases, requiring a thorough evaluation and prompt management.
Tags: pyoderma gangrenosum, ulcer